Journals / Retina-Vitreus / 2009 / Cilt: 17 - Sayı: 1

Central serous chorioretinopathy after epidural corticosteroid injection

Epidural kortikosteroid enjeksiyonu sonrasında gelişen santral seröz korioretinopati

Pages
57–60
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In patients having bilateral CSCR and/or diffuse pigment epitheliopathy, a careful history should be taken including epidural steroid injection in addition to systemic corticosteroid treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We describe a case of central serous chorioretinopathy (CSCR) after epidural corticosteroid injection for the treatment of lower back pain related to lumbar hernia.
📊
Key Findings & Data:A 45-year-old man presented with blurry and decreased vision in both eyes.
💡
Conclusion & Impact:In patients having bilateral CSCR and/or diffuse pigment epitheliopathy, a careful history should be taken including epidural steroid injection in addition to systemic corticosteroid treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Fundus okuli · Enjeksiyon · epidural

Abstract

We describe a case of central serous chorioretinopathy (CSCR) after epidural corticosteroid injection for the treatment of lower back pain related to lumbar hernia. A 45-year-old man presented with blurry and decreased vision in both eyes. Bilateral (CSCR) with multiple focus and diffuse pigment epitheliopathy in the left eye was detected in the fundus examination. All patients receiving systemic corticosteroid treatment by any route should be warned about possible visual symptoms and ocular pathologies, and in that case they should refer to an ophthalmologist at that time. In patients having bilateral CSCR and/or diffuse pigment epitheliopathy, a careful history should be taken including epidural steroid injection in addition to systemic corticosteroid treatment.

Özet

Bu çalışmada lomber disk hernisi kökenli bel ağrısı nedeniyle epidural kortikosteroid enjeksiyonu uygulaması sonrasında gelişen santral seröz korioretinopatili (SSKR) bir olgu tartışılmaktadır. Her iki gözde bulanık ve az görme ile başvuran 45 yaşındaki erkek hastada yapılan fundus muayenesinde bilateral ve çok odaklı santral seröz korioretinopati ile sol gözde makulada diffüz pigment epitelyumyopati saptanmıştır. Herhangi bir yolla sistemik kortikosteroid tedavisi uygulanan bütün hastalar olası görsel şikayetler ve oküler patolojiler hakkında önceden uyarılmalı; bu takdirde mutlaka bir göz hekimine başvurmaları konusunda bilgilendirilmelidirler. Bilateral SSKR ve/veya beraberinde diffüz pigment epitelyopati saptanan olgularda sistemik kortikosteroid yanında epidural steroid enjeksiyon öyküsü mutlaka sorgulanmalıdır.

🔖

Cite This Article

DİNÇ, U. A., YENEREL, M., GÖRGÜN, E., KÜÇÜMEN, R. B. (2009). Central serous chorioretinopathy after epidural corticosteroid injection. Retina-Vitreus, Cilt: 17 - Sayı: 1, 57–60. https://ajindex.com/articles/307749

References (15)

  1. Batıoğlu F, Özmert E, Demirel S, ve ark.: Kronik santral seröz korioretinopatide fotodinamik tedavi sonrası OCT ve fundus otoflöresans bulguları. Ret-Vit. 2007;15:99-102
  2. Carvalho-Recchia CA, Yannuzzi LA, Negrao S, et al.: Corticosteroids and central serous chorioretinopathy. Ophthalmology. 2002;109:1834-1837
  3. Pizzimenti JJ, Daniel KP.: Central serous chorioretinopathy after epidural steroid injection. Pharmacotherapy. 2005;25:1141-1146
  4. Tittl MK, Spaide RF, Wong D, et al.: Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol. 1999;128:63-68
  5. Haimovici R, Gragoudas ES, Duker JS, et al.: Central serous retinopathy associated with inhaled or intranasal corticosteroids. Ophthalmology. 1997;104:1653-1660
  6. Wakakura M, Ishikawa S.: Central serous chorioretinopathy complicating systemic corticosteroid treatment. Br J Ophthalmol. 1984;68:329-331
  7. Garg SP, Dada T, Talwar D, et al.: Endogenous cortisol profile in patients with central serous chorioretinopathy. Br J Ophthalmol. 1997;81:962-964
  8. Jampol LM, Weinreb R, Yannuzzi L.: Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies. Ophthalmology. 2002;109:1765-1766
  9. Sakaue M, Hoffman BB.: Glucocorticoids induce transcription and expression of the 1 adrenergic receptor gene in DTTI and MF-2 smooth muscle cells. J Clin Invest. 1991;88:385-389
  10. Hadcock JR, Malbon CC.: Regulation of -adrenergic receptors by “permissive” hormones: glucocorticoids increase steady-state levels of receptor mRNA. Proc Natl Acad Sci USA. 1988;85:8415-8419
  11. Yannuzzi LA.: Type-A behaviour and central serous chorioretinopathy. Retina. 1987;7:111-131
  12. Walker BR, Best R, Shackleton CHL, et al.: Increased vasoconstrictor sensitivity to glucocorticoids in essential hypertension. Hypertension. 1996;27:190-196
  13. Gass JDM, Little H.: Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy. Ophthalmology. 1995;102:737-747
  14. Kao LY.: Bilateral serous retinal detachment resembling central serous chorioretinopathy following epidural steroid injection. Retina. 1998;18:479-481 15. Iida T, Spaide RF, Negrao S, et al.: Central serous chorioretinopathy after epidural corticosteroid injection. Am J Ophthalmol. 2001;132:423-425
  15. Polak BC, Baarsma GS, Snyers B.: Diffuse retinal pigment epitheliopathy comp